Edwards Lifesciences EW
NYSE EW
$102.14 +1.44 (+1.43%)
At close: Nov 6, 2026 · 4:00 PM EST

Edwards Lifesciences (EW) Sale and Maturity of Investments (2009 - 2026)

Updated

Edwards Lifesciences (EW) reported Sale and Maturity of Investments - Total of $492.5 million for Q3 2026, down 28.8% from $691.9 million a year earlier but up 9.8% from the prior quarter.

Analysis

Edwards Lifesciences (EW) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Edwards Lifesciences' Sale and Maturity of Investments - Total came in at $2.38 billion, down 2.2% year-over-year; for FY2025, it was $2.88 billion, up 235.6% from FY2024.

  • Sale and Maturity of Investments - Total has a five-year compound annual growth rate of 29.9% (FY2020 to FY2025).
  • By year, Sale and Maturity of Investments - Total came in at $857.6 million in FY2024 (+19.8%), $715.8 million in FY2023 (-47.3%), $1.36 billion in FY2022 (+156.8%) and $529.2 million in FY2021 (-31.9%).
  • Five-year quarterly Sale and Maturity of Investments - Total spans a low of $134.1 million in Q2 2023 and a high of $845.6 million in Q1 2025.
  • Year over year, Sale and Maturity of Investments - Total has now declined in each of the last three quarters, with growth averaging 130.5% over the last eight quarters.
  • The high point for year-over-year Sale and Maturity of Investments - Total in five years was Q1 2025 (growth of 407.6%); the low point was Q2 2023 (a decline of 62.7%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $448.5 million (Q2 2026), $722.6 million (Q1 2026) and $714.5 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn -
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn -
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn -
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn 2.11 Bn
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn 2.21 Bn
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn 89.00 Mn
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn -
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn 492.50 Mn
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn -
10 Agilent Technologies 49.29 Bn 42.18 Bn 1.04 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 492.50 Mn
Jun 30, 2026 448.50 Mn
Mar 31, 2026 722.60 Mn
Dec 31, 2025 714.50 Mn
Sep 30, 2025 691.90 Mn
Jun 30, 2025 626.10 Mn
Mar 31, 2025 845.60 Mn
Dec 31, 2024 268.10 Mn
Sep 30, 2024 175.90 Mn
Jun 30, 2024 247.00 Mn
Mar 31, 2024 166.60 Mn
Dec 31, 2023 137.40 Mn
Sep 30, 2023 180.40 Mn
Jun 30, 2023 134.10 Mn
Mar 31, 2023 263.90 Mn
Dec 31, 2022 273.50 Mn
Sep 30, 2022 224.00 Mn
Jun 30, 2022 359.60 Mn
Mar 31, 2022 502.00 Mn
Dec 31, 2021 197.10 Mn
API Access

Edwards Lifesciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=EW&period=max&api_key=YOUR_API_KEY